Other languages Medigen Vaccine Biologics Corporation

Equities

6547

TW0006547003

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
52 ^TWD	-0.95%		+1.36%	-25.82%

Mar. 15	Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Medigen Vaccine Biologics Corporation Provides License Covid-19 Vaccine to WHO C-TAP and UN Medicines Patent Pool	23-08-29
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Medigen Vaccine Biologics Corporation Withdraws Covid-19 Vaccine Provisional Application and Update with Three-Dose Data for Further Review	23-07-21
Medigen Vaccine Biologics Corporation Approves the Election of Ming-Yi ,Wu as Independent Director and Member of Audit and Remuneration Committees	23-06-29
Medigen Vaccine Biologics Corporation Files New Drug Application of MVC EV71 Vaccine to Drug Administration of Vietnam	23-05-24
Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-15
Medigen Vaccine Biologics Corporation Announces Board Changes	23-03-08
Medigen Vaccine Biologics Corporation Announces the Resignation of Chang, Ming-Cheng as Independent Director	23-03-08
Medigen Vaccine Biologics Corporation Receives the NDA Approval Letter of Mvcquadrivalent Influenza Vaccine from Taiwan Food and Drug Administration	23-03-08
Medigen Vaccine Biologics Corporation Announces Results of MVC COVID-19 Vaccine Phase 3 Clinical Trial in Thailand	22-12-05
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11
MVC File Provisional Approval Application of COVID-19 Vaccine to Therapeutic Goods Administration	22-06-06
Medigen Vaccine Biologics Corporation Announces Update on Clinical Development on MVC Covid-19 Vaccine	22-05-13
Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12
Taiwan approves second COVID booster dose, infections yet to peak	22-04-21
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Medigen Vaccine Biologics Corporation

Equities

6547

TW0006547003

Other languages

Filters